The authors hypothesize this cytotoxic response is a re-activation of pre-existing T-cells targeting the HER2/Neu antigen due to the close proximity facilitated by binding of ESK1-BiTE to WT1 on the tumor and CD3 on the T-cell. This evidence concerns the gene CEP70 and neoplasm.